NDC 21922-045 – Mesalamine
Mesalamine 4 g/60mL · Suspension · Rectal
Product NDC21922-045
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- Encube Ethicals, Inc.
- Dosage form
- Suspension
- Route
- Rectal
- Marketing category
- ANDA · ANDA216941
- Marketed since
- June 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 4 g/60mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 21922-045-47 | 7 BOTTLE, DISPENSING in 1 CARTON (21922-045-47) / 60 mL in 1 BOTTLE, DISPENSING (21922-045-01) | Jun 1, 2023 |
| 21922-045-49 | 28 BOTTLE, DISPENSING in 1 CARTON (21922-045-49) / 60 mL in 1 BOTTLE, DISPENSING (21922-045-01) | Jun 1, 2023 |
Other Mesalamine products
- 70954-301 Mesalamine 4 g/60mL · Suspension · ANI Pharmaceuticals, Inc.
- 72162-2302 Mesalamine 4 g/60mL · Suspension · Bryant Ranch Prepack
- 84725-002 Mesalamine 4 g/60mL · Suspension · KLM Laboratories Private Limited
- 0472-1915 Mesalamine 1000 mg/1 · Suppository · Actavis Pharma, Inc.
- 0591-2245 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Actavis Pharma, Inc.
- 62332-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Limited
- 60687-556 Mesalamine 400 mg/1 · Capsule, Delayed Release · American Health Packaging
- 60687-397 Mesalamine 1.2 g/1 · Tablet, Delayed Release · American Health Packaging
- 60687-408 Mesalamine 800 mg/1 · Tablet, Delayed Release · American Health Packaging
- 60687-650 Mesalamine .375 g/1 · Capsule, Extended Release · American Health Packaging
- 65162-360 Mesalamine 800 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals LLC